SIM
FOLD

Sonora Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Sonora Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-750
Closed -$12K – 922
2015
Q3 		$12K Buy
+750
New +$11.8K ﹤0.01% 436

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sonora Investment Management's FOLD Position: Q4 2015 in Review

Sonora Investment Management sold out of Amicus Therapeutics (FOLD) in Q4 2015, closing a stake of 750 shares — an estimated $12K sold.

Sonora Investment Management first reported a position in FOLD in Q3 2015 and held it in 1 quarter. The position peaked at $12K in Q3 2015. 139 funds tracked by Wall St. Rank hold FOLD as of Q4 2015.

  • Sonora Investment Management reported no remaining Amicus Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Sonora Investment Management sold 750 Amicus Therapeutics shares in Q4 2015, an estimated $12K.
  • Sonora Investment Management first reported a position in Amicus Therapeutics in Q3 2015 and held it in 1 quarter.
  • Sonora Investment Management's Amicus Therapeutics position peaked at $12K in Q3 2015.
  • 139 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2015.

Based on Sonora Investment Management's 13F filing for Q4 2015, filed 10 Mar 2016.